{"title":"18F-FDG PET对复发性头颈癌患者治疗的影响：荟萃分析","authors":"Hai-Jeon Yoon, Kyoungjune Pak","doi":"10.1097/MNM.0000000000002005","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Head and neck cancers (HNC) comprise malignancies occurring in the oral cavity, pharynx, larynx, and salivary glands. This meta-analysis assessed the effect of 18F-fluorodeoxyglucose (FDG) PET on the management of recurrent HNC.</p><p><strong>Methods: </strong>We conducted systematic reviews focused on the role of FDG PET in managing recurrent HNC. We defined management change as the percentage of patients whose treatment was altered following FDG PET results relative to those assessed with this imaging technique.</p><p><strong>Results: </strong>We included seven studies encompassing 444 patients. The studies evaluated the role of FDG PET in detecting recurrence or metastasis in HNC patients by examining the rates of management change, with a pooled effect of 26.6%.</p><p><strong>Conclusion: </strong>The findings from our meta-analysis indicate that FDG PET substantially affects the management of patients with recurrent HNC. These outcomes align with current guidelines recommending the use of FDG PET under these circumstances.</p>","PeriodicalId":19708,"journal":{"name":"Nuclear Medicine Communications","volume":" ","pages":""},"PeriodicalIF":1.3000,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact of 18F-FDG PET on management in patients with recurrent head and neck cancer: a meta-analysis.\",\"authors\":\"Hai-Jeon Yoon, Kyoungjune Pak\",\"doi\":\"10.1097/MNM.0000000000002005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Head and neck cancers (HNC) comprise malignancies occurring in the oral cavity, pharynx, larynx, and salivary glands. This meta-analysis assessed the effect of 18F-fluorodeoxyglucose (FDG) PET on the management of recurrent HNC.</p><p><strong>Methods: </strong>We conducted systematic reviews focused on the role of FDG PET in managing recurrent HNC. We defined management change as the percentage of patients whose treatment was altered following FDG PET results relative to those assessed with this imaging technique.</p><p><strong>Results: </strong>We included seven studies encompassing 444 patients. The studies evaluated the role of FDG PET in detecting recurrence or metastasis in HNC patients by examining the rates of management change, with a pooled effect of 26.6%.</p><p><strong>Conclusion: </strong>The findings from our meta-analysis indicate that FDG PET substantially affects the management of patients with recurrent HNC. These outcomes align with current guidelines recommending the use of FDG PET under these circumstances.</p>\",\"PeriodicalId\":19708,\"journal\":{\"name\":\"Nuclear Medicine Communications\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2025-06-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nuclear Medicine Communications\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/MNM.0000000000002005\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nuclear Medicine Communications","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MNM.0000000000002005","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
Impact of 18F-FDG PET on management in patients with recurrent head and neck cancer: a meta-analysis.
Objective: Head and neck cancers (HNC) comprise malignancies occurring in the oral cavity, pharynx, larynx, and salivary glands. This meta-analysis assessed the effect of 18F-fluorodeoxyglucose (FDG) PET on the management of recurrent HNC.
Methods: We conducted systematic reviews focused on the role of FDG PET in managing recurrent HNC. We defined management change as the percentage of patients whose treatment was altered following FDG PET results relative to those assessed with this imaging technique.
Results: We included seven studies encompassing 444 patients. The studies evaluated the role of FDG PET in detecting recurrence or metastasis in HNC patients by examining the rates of management change, with a pooled effect of 26.6%.
Conclusion: The findings from our meta-analysis indicate that FDG PET substantially affects the management of patients with recurrent HNC. These outcomes align with current guidelines recommending the use of FDG PET under these circumstances.
期刊介绍：
Nuclear Medicine Communications, the official journal of the British Nuclear Medicine Society, is a rapid communications journal covering nuclear medicine and molecular imaging with radionuclides, and the basic supporting sciences. As well as clinical research and commentary, manuscripts describing research on preclinical and basic sciences (radiochemistry, radiopharmacy, radiobiology, radiopharmacology, medical physics, computing and engineering, and technical and nursing professions involved in delivering nuclear medicine services) are welcomed, as the journal is intended to be of interest internationally to all members of the many medical and non-medical disciplines involved in nuclear medicine. In addition to papers reporting original studies, frankly written editorials and topical reviews are a regular feature of the journal.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
